Shanghai Capital Expenditures vs Change To Operating Activities Analysis

601607 Stock

21.75 0.07 0.32%

Shanghai Pharmaceuticals financial indicator trend analysis is much more than just breaking down Shanghai Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Shanghai Pharmaceuticals is a good investment. Please check the relationship between Shanghai Pharmaceuticals Capital Expenditures and its Change To Operating Activities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai Pharmaceuticals Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Capital Expenditures vs Change To Operating Activities

Capital Expenditures vs Change To Operating Activities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Shanghai Pharmaceuticals Capital Expenditures account and Change To Operating Activities. At this time, the significance of the direction appears to have pay attention.

The correlation between Shanghai Pharmaceuticals' Capital Expenditures and Change To Operating Activities is -0.81. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Change To Operating Activities in the same time period over historical financial statements of Shanghai Pharmaceuticals Holding, assuming nothing else is changed. The correlation between historical values of Shanghai Pharmaceuticals' Capital Expenditures and Change To Operating Activities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Shanghai Pharmaceuticals Holding are associated (or correlated) with its Change To Operating Activities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Operating Activities has no effect on the direction of Capital Expenditures i.e., Shanghai Pharmaceuticals' Capital Expenditures and Change To Operating Activities go up and down completely randomly.

Correlation Coefficient

-0.81

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Capital Expenditures

Capital Expenditures are funds used by Shanghai Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Shanghai Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Change To Operating Activities

Most indicators from Shanghai Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Shanghai Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai Pharmaceuticals Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Selling General Administrative is expected to grow to about 16.4 B, whereas Tax Provision is forecasted to decline to about 1.6 B.

	2021	2022	2023	2024 (projected)
Operating Income	7.9B	8.8B	9.6B	10.0B
Total Revenue	215.8B	232.0B	260.3B	273.3B

Operating Income Total Revenue

Shanghai Pharmaceuticals fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Other Liab	Good Will	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt
Total Assets		0.66	1.0	0.98	0.99	0.99	0.97	0.78	0.72	1.0	0.89	0.99	0.37	1.0	0.69	0.83	0.99	0.98	0.85	0.85	-0.51	0.66	0.89	0.92	0.92	0.85
Other Current Liab	0.66		0.66	0.58	0.72	0.65	0.6	0.72	0.66	0.69	0.76	0.64	0.85	0.69	0.49	0.4	0.73	0.69	0.92	0.62	-0.73	0.88	0.77	0.75	0.66	0.87
Total Current Liabilities	1.0	0.66		0.97	0.99	0.99	0.96	0.77	0.71	1.0	0.9	0.99	0.37	1.0	0.67	0.8	0.99	0.98	0.84	0.86	-0.51	0.67	0.9	0.92	0.92	0.86
Total Stockholder Equity	0.98	0.58	0.97		0.97	0.99	0.98	0.72	0.65	0.97	0.81	0.98	0.29	0.97	0.75	0.9	0.96	0.95	0.79	0.82	-0.4	0.54	0.83	0.86	0.88	0.77
Retained Earnings	0.99	0.72	0.99	0.97		0.99	0.95	0.8	0.73	0.99	0.89	0.98	0.46	0.99	0.67	0.79	0.99	0.98	0.88	0.85	-0.52	0.7	0.9	0.92	0.91	0.88
Accounts Payable	0.99	0.65	0.99	0.99	0.99		0.96	0.8	0.73	0.99	0.86	1.0	0.4	0.99	0.68	0.85	0.98	0.96	0.85	0.82	-0.51	0.64	0.87	0.9	0.89	0.84
Cash	0.97	0.6	0.96	0.98	0.95	0.96		0.68	0.62	0.95	0.83	0.96	0.29	0.96	0.79	0.91	0.95	0.94	0.78	0.82	-0.43	0.59	0.82	0.84	0.87	0.77
Other Assets	0.78	0.72	0.77	0.72	0.8	0.8	0.68		0.83	0.82	0.77	0.8	0.63	0.79	0.38	0.59	0.81	0.75	0.82	0.57	-0.78	0.74	0.8	0.81	0.66	0.83
Long Term Debt	0.72	0.66	0.71	0.65	0.73	0.73	0.62	0.83		0.75	0.82	0.75	0.49	0.75	0.36	0.46	0.73	0.68	0.8	0.53	-0.83	0.74	0.71	0.81	0.68	0.81
Net Receivables	1.0	0.69	1.0	0.97	0.99	0.99	0.95	0.82	0.75		0.91	0.99	0.43	1.0	0.66	0.8	0.99	0.98	0.87	0.84	-0.56	0.7	0.9	0.93	0.91	0.88
Short Term Investments	0.89	0.76	0.9	0.81	0.89	0.86	0.83	0.77	0.82	0.91		0.88	0.47	0.92	0.59	0.58	0.91	0.88	0.88	0.77	-0.76	0.85	0.86	0.9	0.88	0.89
Inventory	0.99	0.64	0.99	0.98	0.98	1.0	0.96	0.8	0.75	0.99	0.88		0.38	0.99	0.68	0.85	0.97	0.96	0.85	0.81	-0.53	0.64	0.87	0.91	0.9	0.84
Other Current Assets	0.37	0.85	0.37	0.29	0.46	0.4	0.29	0.63	0.49	0.43	0.47	0.38		0.4	0.18	0.19	0.46	0.42	0.7	0.21	-0.63	0.78	0.46	0.43	0.25	0.6
Total Liab	1.0	0.69	1.0	0.97	0.99	0.99	0.96	0.79	0.75	1.0	0.92	0.99	0.4		0.66	0.79	0.99	0.98	0.86	0.85	-0.55	0.71	0.91	0.93	0.92	0.88
Intangible Assets	0.69	0.49	0.67	0.75	0.67	0.68	0.79	0.38	0.36	0.66	0.59	0.68	0.18	0.66		0.78	0.67	0.66	0.56	0.6	-0.21	0.39	0.51	0.51	0.61	0.46
Common Stock	0.83	0.4	0.8	0.9	0.79	0.85	0.91	0.59	0.46	0.8	0.58	0.85	0.19	0.79	0.78		0.78	0.76	0.61	0.61	-0.25	0.32	0.6	0.63	0.65	0.53
Property Plant Equipment	0.99	0.73	0.99	0.96	0.99	0.98	0.95	0.81	0.73	0.99	0.91	0.97	0.46	0.99	0.67	0.78		0.99	0.87	0.86	-0.55	0.74	0.92	0.93	0.9	0.89
Other Liab	0.98	0.69	0.98	0.95	0.98	0.96	0.94	0.75	0.68	0.98	0.88	0.96	0.42	0.98	0.66	0.76	0.99		0.83	0.87	-0.47	0.7	0.92	0.92	0.9	0.87
Good Will	0.85	0.92	0.84	0.79	0.88	0.85	0.78	0.82	0.8	0.87	0.88	0.85	0.7	0.86	0.56	0.61	0.87	0.83		0.73	-0.76	0.81	0.88	0.91	0.83	0.95
Net Tangible Assets	0.85	0.62	0.86	0.82	0.85	0.82	0.82	0.57	0.53	0.84	0.77	0.81	0.21	0.85	0.6	0.61	0.86	0.87	0.73		-0.3	0.53	0.91	0.88	0.95	0.81
Other Stockholder Equity	-0.51	-0.73	-0.51	-0.4	-0.52	-0.51	-0.43	-0.78	-0.83	-0.56	-0.76	-0.53	-0.63	-0.55	-0.21	-0.25	-0.55	-0.47	-0.76	-0.3		-0.81	-0.58	-0.65	-0.49	-0.73
Deferred Long Term Liab	0.66	0.88	0.67	0.54	0.7	0.64	0.59	0.74	0.74	0.7	0.85	0.64	0.78	0.71	0.39	0.32	0.74	0.7	0.81	0.53	-0.81		0.72	0.72	0.59	0.82
Long Term Investments	0.89	0.77	0.9	0.83	0.9	0.87	0.82	0.8	0.71	0.9	0.86	0.87	0.46	0.91	0.51	0.6	0.92	0.92	0.88	0.91	-0.58	0.72		0.98	0.93	0.96
Short Long Term Debt	0.92	0.75	0.92	0.86	0.92	0.9	0.84	0.81	0.81	0.93	0.9	0.91	0.43	0.93	0.51	0.63	0.93	0.92	0.91	0.88	-0.65	0.72	0.98		0.95	0.97
Total Current Assets	0.92	0.66	0.92	0.88	0.91	0.89	0.87	0.66	0.68	0.91	0.88	0.9	0.25	0.92	0.61	0.65	0.9	0.9	0.83	0.95	-0.49	0.59	0.93	0.95		0.88
Short Term Debt	0.85	0.87	0.86	0.77	0.88	0.84	0.77	0.83	0.81	0.88	0.89	0.84	0.6	0.88	0.46	0.53	0.89	0.87	0.95	0.81	-0.73	0.82	0.96	0.97	0.88

Click cells to compare fundamentals

Shanghai Pharmaceuticals Account Relationship Matchups

Shanghai Pharmaceuticals fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	137.0B	149.2B	163.4B	198.1B	212.0B	222.6B
Other Current Liab	8.0B	9.5B	9.7B	6.4B	6.3B	3.5B
Total Current Liabilities	74.6B	88.1B	91.8B	110.7B	122.4B	128.5B
Total Stockholder Equity	41.7B	45.4B	49.4B	67.1B	68.5B	72.0B
Retained Earnings	23.6B	26.9B	30.6B	34.6B	33.8B	35.5B
Accounts Payable	36.9B	37.8B	42.0B	51.6B	54.6B	57.4B
Cash	18.2B	22.3B	22.4B	27.4B	30.5B	32.0B
Other Assets	2.9B	5.7B	2.8B	3.0B	3.5B	3.7B
Long Term Debt	9.1B	1.2B	7.2B	6.3B	5.8B	6.1B
Net Receivables	51.3B	52.7B	58.1B	66.8B	72.9B	76.6B
Inventory	24.9B	24.1B	27.1B	34.5B	36.6B	38.5B
Other Current Assets	3.7B	4.3B	4.2B	1.4B	1.4B	1.5B
Total Liab	87.6B	94.4B	104.4B	120.1B	131.6B	138.2B
Intangible Assets	4.1B	5.4B	6.3B	6.6B	6.4B	6.7B
Property Plant Equipment	10.6B	13.1B	14.6B	15.8B	18.2B	19.1B
Other Liab	2.1B	2.7B	3.6B	4.0B	4.5B	4.8B
Good Will	10.8B	11.3B	11.2B	11.3B	11.4B	7.3B
Net Tangible Assets	23.6B	26.9B	28.8B	32.1B	36.9B	28.6B
Other Stockholder Equity	(492.6M)	(542.2M)	(265.4M)	(144.4M)	(130.0M)	(136.5M)
Deferred Long Term Liab	606.4M	639.1M	688.3M	342.6M	394.0M	504.8M
Short Long Term Debt	23.1B	20.1B	22.5B	27.8B	35.6B	21.0B
Total Current Assets	98.1B	107.6B	116.5B	149.5B	162.4B	111.5B
Non Current Assets Total	38.9B	41.6B	46.9B	48.6B	49.5B	42.3B
Non Currrent Assets Other	3.3B	12.6B	856.9M	443.8M	440.7M	418.7M
Non Current Liabilities Total	13.0B	6.3B	12.5B	9.4B	9.3B	9.9B
Non Current Liabilities Other	190.9M	170.4M	566.1M	257.3M	250.1M	274.1M
Net Debt	10.3B	14.1B	7.3B	6.6B	10.8B	9.3B
Net Invested Capital	73.9B	66.7B	79.0B	101.1B	109.9B	86.3B
Net Working Capital	23.5B	19.4B	24.7B	38.8B	40.1B	29.9B

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Shanghai Stock

Balance Sheet is a snapshot of the financial position of Shanghai Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Shanghai Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Shanghai Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Shanghai currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shanghai Capital Expenditures vs Change To Operating Activities Analysis

Capital Expenditures vs Change To Operating Activities

Capital Expenditures vs Change To Operating Activities Correlation Analysis

Correlation Coefficient

Capital Expenditures

Change To Operating Activities

Shanghai Pharmaceuticals fundamental ratios Correlations

Shanghai Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shanghai Pharmaceuticals fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Net Receivables	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Net Receivables	+ 1.0	Total Current Liabilities
Total Liab	+ 1.0	Total Current Liabilities
Inventory	+ 1.0	Accounts Payable

Other Stockholder Equity	- 0.83	Long Term Debt
Deferred Long Term Liab	- 0.81	Other Stockholder Equity
Other Stockholder Equity	- 0.78	Other Assets
Other Stockholder Equity	- 0.76	Good Will
Other Stockholder Equity	- 0.76	Short Term Investments
Short Term Debt	- 0.73	Other Stockholder Equity